Dr. Dominick Joseph Angiolillo, MD

Dr. Angiolillo practices at UF Health Rehabilitation Hospital - North in Jacksonville, Florida, part of UF Health.

Dr. Angiolillo's NPI, 1578687844, was assigned on March 19, 2007. Dr. Angiolillo graduated from University of Cattolica del Sacro Cuore in 1997. Dr. Angiolillo holds Florida license ME99467.

Dr. Angiolillo's primary practice is UF Health Rehabilitation Hospital - North, at 15255 Max Leggett Pkwy, 2nd and 3rd Floors, Jacksonville, FL 32218 in Duval County. The practice phone is (904) 456-8001.

Dr. Angiolillo's primary practice is UF Health Rehabilitation Hospital - North in Jacksonville, Florida, part of UF Health. Dr. Angiolillo is also affiliated with UF Health Jacksonville. The medical group on file is UF Jacksonville Physicians, Inc. Dmand AI also links Dr. Angiolillo to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Angiolillo practices, 4 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Angiolillo's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Angiolillo is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Angiolillo is licensed in Florida.

Dmand AI lists angioplasty and cardiac catheterization among the conditions Dr. Angiolillo treats.

CMS data shows 4,222 Medicare services from Dr. Angiolillo across 6 procedure codes in 2024, for 2,341 Medicare patients. Medicare paid $45,645 for them.

CMS counts 2,341 Medicare patients who saw Dr. Angiolillo in 2024. The largest group is 65 to 74, with 934 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 29% are also on Medicaid. Their average risk score is 2.19, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Angiolillo's median patient age at 68, with 53% women.

In 2024, Dr. Angiolillo wrote 1,234 Medicare Part D claims for 226 patients. 90% of them were for generic drugs. CMS names the drug for 1,099 of them, across 21 drugs with 11 or more claims each, at $84,706 in total drug cost. In 2023, CMS named 857 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 60 out of 100 for Dr. Angiolillo for performance year 2024, reported through an alternative payment model (APM). Dr. Angiolillo accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 736 papers to Dr. Angiolillo, published from 2003 to 2025. 2020 was the busiest year, with 56. The most frequent topics are Platelet Aggregation Inhibitors, Percutaneous Coronary Intervention and Clopidogrel. Dr. Angiolillo has published most often in J Am Coll Cardiol. Dr. Angiolillo's most frequent co-authors are Francesco Franchi, MD, Fabiana Rollini, MD and Roxana Mehran, MD.

Dmand AI links Dr. Angiolillo to 33 clinical trials, 19 of them phase 4 studies. 1 is still active or recruiting. Conditions studied include Coronary Artery Disease, Coronary Disease and Myocardial Infarction. University of Florida sponsors the most, 27.

CMS Open Payments shows 297 general payments to Dr. Angiolillo from 24 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 61% of the total. Sanofi and Genzyme US Companies paid the most, $182,827. It also lists 1 research payment totaling $125 in 2016.

Dmand AI lists 1 award for Dr. Angiolillo.

Dr. Angiolillo graduated from University of Cattolica del Sacro Cuore in 1997. Dr. Angiolillo is a member of ACC.

Dr. Angiolillo is in network with 19 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.